Sign in
4

Changes in Ownership

Ascendis Pharma A/S Filed Acc 0001610717-26-000179

EVP & Chief Financial Officer bought 100 shares at $219.00 ($21,900)

From the SEC's structured data for this filing

Trades in this filing

SMITH SCOTT THOMAS · EVP & Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-02 Purchase : show line 1 in the form +100 $219.00 $21,900 4,367 D
Open-market purchases · 100 sh · avg $219.00 · $21,900
Loading xslF345X06/form4.xml…